Aptose Biosciences Ownership 2024 | Who Owns Aptose Biosciences Now?

Overview RevenueFinancials Chart Transcripts

Institutional Ownership

0.00%

Insider Ownership

17.11%

Retail Ownership

82.89%

Institutional Holders

1.00

Aptose Biosciences Institutional Shareholders

Institutional Shareholders by % of Total Shares

Name	% Total Shares	% Total Assets	Current Shares	Change Amount	Change %	Market Value	Date
ANNANDALE CAPITAL, LLC	0.39%	0.01%	26,666	-48,000	-64.29%	44,000	Mar 31, 2024
CALDWELL SUTTER CAPITAL, INC.	0.00%	0.00%	92	-	-	153	Mar 31, 2024

Aptose Biosciences's largest institutional shareholder is ANNANDALE CAPITAL, LLC, holding 0.39% of the company's total share outstanding, currently valued at $44.00K. The top 10 institutional shareholders own together 0.40% of the company.

Institutional Shareholders by % of Total Assets

Name	% Total Shares	% Total Assets	Current Shares	Change Amount	Change %	Market Value	Date
ANNANDALE CAPITAL, LLC	0.39%	0.01%	26,666	-48,000	-64.29%	44,000	Mar 31, 2024
CALDWELL SUTTER CAPITAL, INC.	0.00%	0.00%	92	-	-	153	Mar 31, 2024

The largest Aptose Biosciences shareholder by % of total assets is ANNANDALE CAPITAL, LLC. The company owns 26.67K shares of Aptose Biosciences (APTO), representing 0.01% of its total assets.

Institutional Buyers

Name	% Total Shares	% Total Assets	Current Shares	Change Amount	Change %	Market Value	Date
CALDWELL SUTTER CAPITAL, INC.	0.00%	0.00%	92	-	-	153	Mar 31, 2024
ANNANDALE CAPITAL, LLC	0.39%	0.01%	26,666	-48,000	-64.29%	44,000	Mar 31, 2024

As of Mar 31 2024, Aptose Biosciences's largest institutional buyer is CALDWELL SUTTER CAPITAL, INC.. The company purchased 0.00 stocks of APTO, valued at $153.00.

Institutional Sellers

Name	% Total Shares	% Total Assets	Current Shares	Change Amount	Change %	Market Value	Date
ANNANDALE CAPITAL, LLC	0.39%	0.01%	26,666	-48,000	-64.29%	44,000	Mar 31, 2024
CALDWELL SUTTER CAPITAL, INC.	0.00%	0.00%	92	-	-	153	Mar 31, 2024

As of Mar 31 2024, Aptose Biosciences's biggest institutional seller is ANNANDALE CAPITAL, LLC. The company sold -48.00K shares of APTO, valued at $44.00K.

Institutional New positions

Name	% Total Shares	% Total Assets	Current Shares	Change Amount	Change %	Market Value	Date

Institutional Sold Out

Name	% Total Shares	% Total Assets	Current Shares	Change Amount	Change %	Market Value	Date

Aptose Biosciences Mutual Fund Holders

Name	% Total Assets	Total Shares	Change Amount	Change %	Date
DRIEHAUS MUTUAL FUNDS	0.02%	157,219	-	-	Dec 29, 2023
RBB FUND, INC.	0.00%	93,697	-	-	Feb 29, 2024
MUTUAL FUND SERIES TRUST	0.00%	2,299,000	-	-	Dec 31, 2023
FIDELITY CONCORD STREET TRUST	0.00%	32,455	-	-	Feb 29, 2024
DFA INVESTMENT TRUST CO	0.00%	767	-	-	Jan 31, 2024
DFA INVESTMENT TRUST CO	0.00%	766	-	-	Jan 31, 2024

Aptose Biosciences's largest mutual fund holder by % of total assets is "DRIEHAUS MUTUAL FUNDS", owning 157.22K shares, compromising 0.02% of its total assets.

Aptose Biosciences Institutional Ownership Trends

Institutional Holdings Trend

Date	Holdings	Change %
31 Mar, 24	1	-50.00%
31 Dec, 23	2	-
30 Sep, 23	2	-
30 Jun, 23	2	-95.65%
31 Mar, 23	46	-8.00%
31 Dec, 22	50	2.04%
30 Sep, 22	49	-
30 Jun, 22	49	-10.91%
31 Mar, 22	55	-6.78%
31 Dec, 21	59	-11.94%
30 Sep, 21	67	-1.47%
30 Jun, 21	68	-11.69%
31 Mar, 21	77	11.59%
31 Dec, 20	69	1.47%
30 Sep, 20	68	15.25%
30 Jun, 20	59	7.27%
31 Mar, 20	55	-3.51%
31 Dec, 19	57	96.55%
30 Sep, 19	29	3.57%
30 Jun, 19	28	33.33%
31 Mar, 19	21	16.67%
31 Dec, 18	18	20.00%
30 Sep, 18	15	-21.05%
30 Jun, 18	19	18.75%
31 Mar, 18	16	14.29%
31 Dec, 17	14	27.27%
30 Sep, 17	11	22.22%
30 Jun, 17	9	-18.18%
31 Mar, 17	11	-8.33%
31 Dec, 16	12	20.00%
30 Sep, 16	10	-
30 Jun, 16	10	-16.67%
31 Mar, 16	12	9.09%
31 Dec, 15	11	-8.33%
30 Sep, 15	12	-25.00%
30 Jun, 15	16	23.08%
31 Mar, 15	13	85.71%
31 Dec, 14	7	-

As of 31 Mar 24, 1 institutions are holding Aptose Biosciences's shares, representing a decrease of -50.00% compared to the previous quarter.

Shares Outstanding Trend

Date	Shares Outstanding	Change %
31 Mar, 24	92	-99.88%
31 Dec, 23	74,758	-
30 Sep, 23	74,758	39.93%
30 Jun, 23	53,424	-99.75%
31 Mar, 23	21,228,131	-8.64%
31 Dec, 22	23,236,335	-5.78%
30 Sep, 22	24,662,522	-2.02%
30 Jun, 22	25,169,814	-12.09%
31 Mar, 22	28,631,055	-8.25%
31 Dec, 21	31,205,099	-21.02%
30 Sep, 21	39,510,111	-16.19%
30 Jun, 21	47,139,717	-9.98%
31 Mar, 21	52,368,085	7.61%
31 Dec, 20	48,664,162	5.02%
30 Sep, 20	46,338,283	29.35%
30 Jun, 20	35,824,440	2.28%
31 Mar, 20	35,025,898	14.52%
31 Dec, 19	30,583,878	117.30%
30 Sep, 19	14,074,779	18.54%
30 Jun, 19	11,873,847	261.62%
31 Mar, 19	3,283,483	6.78%
31 Dec, 18	3,074,956	154.35%
30 Sep, 18	1,208,970	53.11%
30 Jun, 18	789,587	65.00%
31 Mar, 18	478,530	33.02%
31 Dec, 17	359,752	68.70%
30 Sep, 17	213,254	-80.37%
30 Jun, 17	1,086,453	-55.26%
31 Mar, 17	2,428,382	-9.73%
31 Dec, 16	2,690,112	-7.24%
30 Sep, 16	2,899,922	15.80%
30 Jun, 16	2,504,257	-4.72%
31 Mar, 16	2,628,228	-0.20%
31 Dec, 15	2,633,617	-4.28%
30 Sep, 15	2,751,269	-12.18%
30 Jun, 15	3,132,731	7.21%
31 Mar, 15	2,921,982	-7.49%
31 Dec, 14	3,158,683	-

Aptose Biosciences (APTO) has 92.00 shares outstanding as of 31 Mar 24, down -99.88% compared to the previous quarter.

Institutional Ownership Trend

Date	Ownership %	Change %
31 Mar, 24	0.00%	0.10%
31 Dec, 23	1.15%	0.36%
30 Sep, 23	17.99%	540135.36%
30 Jun, 23	0.06%	0.01%
31 Mar, 23	22.93%	3.62%
31 Dec, 22	25.18%	3.53%
30 Sep, 22	26.72%	3.59%
30 Jun, 22	27.29%	2.83%
31 Mar, 22	31.04%	2.53%
31 Dec, 21	35.03%	1.78%
30 Sep, 21	44.42%	1.58%
30 Jun, 21	53.00%	1.53%
31 Mar, 21	58.92%	1.67%
31 Dec, 20	59.46%	2.04%
30 Sep, 20	53.97%	2.45%
30 Jun, 20	46.97%	2.22%
31 Mar, 20	45.95%	1.24%
31 Dec, 19	60.97%	9.46%
30 Sep, 19	25.38%	3.89%
30 Jun, 19	25.55%	37.63%
31 Mar, 19	8.24%	9.72%
31 Dec, 18	9.21%	75.37%
30 Sep, 18	3.50%	64.62%
30 Jun, 18	2.33%	85.66%
31 Mar, 18	1.65%	63.39%
31 Dec, 17	1.61%	205.25%
30 Sep, 17	0.89%	3.51%
30 Jun, 17	5.03%	2.59%
31 Mar, 17	13.94%	3.13%
31 Dec, 16	21.11%	4.17%
30 Sep, 16	22.51%	5.37%
30 Jun, 16	20.47%	4.30%
31 Mar, 16	21.81%	4.46%
31 Dec, 15	22.12%	4.14%
30 Sep, 15	23.10%	3.34%
30 Jun, 15	26.31%	4.29%
31 Mar, 15	24.78%	3.36%
31 Dec, 14	27.16%	-

As of 31 Mar 24, Aptose Biosciences is held by 0.00% institutional shareholders, representing a 0.10% growth compared to 31 Dec 23.

Institutional Increased Positions Trend

Date	Increased Positions	Change %
31 Mar, 24	-	-
31 Dec, 23	-	-100.00%
30 Sep, 23	1	-
30 Jun, 23	1	-88.89%
31 Mar, 23	9	-60.87%
31 Dec, 22	23	35.29%
30 Sep, 22	17	41.67%
30 Jun, 22	12	-36.84%
31 Mar, 22	19	-42.42%
31 Dec, 21	33	3.13%
30 Sep, 21	32	18.52%
30 Jun, 21	27	-34.15%
31 Mar, 21	41	10.81%
31 Dec, 20	37	-19.57%
30 Sep, 20	46	43.75%
30 Jun, 20	32	-3.03%
31 Mar, 20	33	-29.79%
31 Dec, 19	47	123.81%
30 Sep, 19	21	-
30 Jun, 19	21	61.54%
31 Mar, 19	13	62.50%
31 Dec, 18	8	-
30 Sep, 18	8	-27.27%
30 Jun, 18	11	22.22%
31 Mar, 18	9	12.50%
31 Dec, 17	8	33.33%
30 Sep, 17	6	100.00%
30 Jun, 17	3	-50.00%
31 Mar, 17	6	20.00%
31 Dec, 16	5	-16.67%
30 Sep, 16	6	100.00%
30 Jun, 16	3	-25.00%
31 Mar, 16	4	-20.00%
31 Dec, 15	5	400.00%
30 Sep, 15	1	-87.50%
30 Jun, 15	8	-11.11%
31 Mar, 15	9	28.57%
31 Dec, 14	7	-

- institutional shareholders have increased their position in APTO stock as of 31 Mar 24 compared to - in the previous quarter (a 0.00% increase).

Institutional Reduced Positions Trend

Date	Reduced Positions	Change %
31 Mar, 24	-	-
31 Dec, 23	-	-
30 Sep, 23	-	-100.00%
30 Jun, 23	1	-92.86%
31 Mar, 23	14	40.00%
31 Dec, 22	10	-9.09%
30 Sep, 22	11	-21.43%
30 Jun, 22	14	-6.67%
31 Mar, 22	15	15.38%
31 Dec, 21	13	-38.10%
30 Sep, 21	21	23.53%
30 Jun, 21	17	-10.53%
31 Mar, 21	19	11.76%
31 Dec, 20	17	70.00%
30 Sep, 20	10	-33.33%
30 Jun, 20	15	15.38%
31 Mar, 20	13	85.71%
31 Dec, 19	7	75.00%
30 Sep, 19	4	33.33%
30 Jun, 19	3	-
31 Mar, 19	3	-25.00%
31 Dec, 18	4	33.33%
30 Sep, 18	3	-25.00%
30 Jun, 18	4	-
31 Mar, 18	4	33.33%
31 Dec, 17	3	-25.00%
30 Sep, 17	4	-
30 Jun, 17	4	100.00%
31 Mar, 17	2	-66.67%
31 Dec, 16	6	500.00%
30 Sep, 16	1	-66.67%
30 Jun, 16	3	-
31 Mar, 16	3	50.00%
31 Dec, 15	2	-71.43%
30 Sep, 15	7	133.33%
30 Jun, 15	3	50.00%
31 Mar, 15	2	-
31 Dec, 14	-	-

- institutional shareholders have reduced their position in APTO stock as of 31 Mar 24 compared to - in the previous quarter (a 0.00% increase).

All Institutional Ownership Trend Data

Date	Holdings	Change %	Shares Outstanding	Change %	Ownership %	Change %	Increased Positions	Change %	Reduced Positions	Change %
31 Mar, 24	1	-50.00%	92	-99.88%	0.00%	0.10%	-	-	-	-
31 Dec, 23	2	-	74,758	-	1.15%	0.36%	-	-100.00%	-	-
30 Sep, 23	2	-	74,758	39.93%	17.99%	540135.36%	1	-	-	-100.00%
30 Jun, 23	2	-95.65%	53,424	-99.75%	0.06%	0.01%	1	-88.89%	1	-92.86%
31 Mar, 23	46	-8.00%	21,228,131	-8.64%	22.93%	3.62%	9	-60.87%	14	40.00%
31 Dec, 22	50	2.04%	23,236,335	-5.78%	25.18%	3.53%	23	35.29%	10	-9.09%
30 Sep, 22	49	-	24,662,522	-2.02%	26.72%	3.59%	17	41.67%	11	-21.43%
30 Jun, 22	49	-10.91%	25,169,814	-12.09%	27.29%	2.83%	12	-36.84%	14	-6.67%
31 Mar, 22	55	-6.78%	28,631,055	-8.25%	31.04%	2.53%	19	-42.42%	15	15.38%
31 Dec, 21	59	-11.94%	31,205,099	-21.02%	35.03%	1.78%	33	3.13%	13	-38.10%
30 Sep, 21	67	-1.47%	39,510,111	-16.19%	44.42%	1.58%	32	18.52%	21	23.53%
30 Jun, 21	68	-11.69%	47,139,717	-9.98%	53.00%	1.53%	27	-34.15%	17	-10.53%
31 Mar, 21	77	11.59%	52,368,085	7.61%	58.92%	1.67%	41	10.81%	19	11.76%
31 Dec, 20	69	1.47%	48,664,162	5.02%	59.46%	2.04%	37	-19.57%	17	70.00%
30 Sep, 20	68	15.25%	46,338,283	29.35%	53.97%	2.45%	46	43.75%	10	-33.33%
30 Jun, 20	59	7.27%	35,824,440	2.28%	46.97%	2.22%	32	-3.03%	15	15.38%
31 Mar, 20	55	-3.51%	35,025,898	14.52%	45.95%	1.24%	33	-29.79%	13	85.71%
31 Dec, 19	57	96.55%	30,583,878	117.30%	60.97%	9.46%	47	123.81%	7	75.00%
30 Sep, 19	29	3.57%	14,074,779	18.54%	25.38%	3.89%	21	-	4	33.33%
30 Jun, 19	28	33.33%	11,873,847	261.62%	25.55%	37.63%	21	61.54%	3	-
31 Mar, 19	21	16.67%	3,283,483	6.78%	8.24%	9.72%	13	62.50%	3	-25.00%
31 Dec, 18	18	20.00%	3,074,956	154.35%	9.21%	75.37%	8	-	4	33.33%
30 Sep, 18	15	-21.05%	1,208,970	53.11%	3.50%	64.62%	8	-27.27%	3	-25.00%
30 Jun, 18	19	18.75%	789,587	65.00%	2.33%	85.66%	11	22.22%	4	-
31 Mar, 18	16	14.29%	478,530	33.02%	1.65%	63.39%	9	12.50%	4	33.33%
31 Dec, 17	14	27.27%	359,752	68.70%	1.61%	205.25%	8	33.33%	3	-25.00%
30 Sep, 17	11	22.22%	213,254	-80.37%	0.89%	3.51%	6	100.00%	4	-
30 Jun, 17	9	-18.18%	1,086,453	-55.26%	5.03%	2.59%	3	-50.00%	4	100.00%
31 Mar, 17	11	-8.33%	2,428,382	-9.73%	13.94%	3.13%	6	20.00%	2	-66.67%
31 Dec, 16	12	20.00%	2,690,112	-7.24%	21.11%	4.17%	5	-16.67%	6	500.00%
30 Sep, 16	10	-	2,899,922	15.80%	22.51%	5.37%	6	100.00%	1	-66.67%
30 Jun, 16	10	-16.67%	2,504,257	-4.72%	20.47%	4.30%	3	-25.00%	3	-
31 Mar, 16	12	9.09%	2,628,228	-0.20%	21.81%	4.46%	4	-20.00%	3	50.00%
31 Dec, 15	11	-8.33%	2,633,617	-4.28%	22.12%	4.14%	5	400.00%	2	-71.43%
30 Sep, 15	12	-25.00%	2,751,269	-12.18%	23.10%	3.34%	1	-87.50%	7	133.33%
30 Jun, 15	16	23.08%	3,132,731	7.21%	26.31%	4.29%	8	-11.11%	3	50.00%
31 Mar, 15	13	85.71%	2,921,982	-7.49%	24.78%	3.36%	9	28.57%	2	-
31 Dec, 14	7	-	3,158,683	-	27.16%	-	7	-	-	-

Aptose Biosciences Insider Shareholders Trades

Open Market Insider Trades

Date	Name	Relation	Role	Transaction	Buy/Sell	Shares	Price	Value	Shares Held	Source
Sep 25, 2023	Seizinger Bernd R.	director	-	P-Purchase	Buy	17,000	$3.14	$53.38K	17,000

Open Market Insider Buys

Date	Name	Relation	Role	Transaction	Buy/Sell	Shares	Price	Value	Shares Held	Source
Sep 25, 2023	Seizinger Bernd R.	director	-	P-Purchase	Buy	17,000	$3.14	$53.38K	17,000

Insider Sells

Date	Name	Relation	Role	Transaction	Buy/Sell	Shares	Price	Value	Shares Held	Source

All Insider Owners Trades

Date	Name	Relation	Role	Transaction	Buy/Sell	Shares	Price	Value	Shares Held
May 10, 2024	LEDRU PHILIPPE		-		Buy	-	-	-	-
Feb 07, 2024	Payne Fletcher	officer	Sr VP and CFO	A-Award	Buy	55,000	$2.00	$110.00K	55,000
Feb 07, 2024	Bejar Rafael	officer	Sr VP & Chief Medical Officer	A-Award	Buy	35,000	$2.00	$70.00K	35,000
Feb 07, 2024	LEDRU PHILIPPE	officer	Sr VP & Ch Commerical Officer	A-Award	Buy	11,000	$2.00	$22.00K	11,000
Feb 07, 2024	Rice William G.	director, officer	Chair, President & CEO	A-Award	Buy	70,000	$2.00	$140.00K	70,000
Feb 07, 2024	Seizinger Bernd R.	director	-	A-Award	Buy	3,333	$2.00	$6.67K	3,333
Feb 07, 2024	PLATZER ERICH	director	-	A-Award	Buy	3,333	$2.00	$6.67K	3,333
Feb 07, 2024	Vincent Mark D.	director	-	A-Award	Buy	3,333	$1.97	$6.57K	3,333
Feb 07, 2024	Ashe Carol Gail	director	-	A-Award	Buy	3,333	$2.00	$6.67K	3,333
Feb 07, 2024	BURGER DENIS R	director	-	A-Award	Buy	3,333	$2.00	$6.67K	3,333
Feb 07, 2024	Whitehead Warren	director	-	A-Award	Buy	3,333	$1.97	$6.57K	3,333
Sep 25, 2023	Seizinger Bernd R.	director	-	P-Purchase	Buy	17,000	$3.14	$53.38K	17,000
Jan 23, 2023	Whitehead Warren	director	-	A-Award	Buy	100,000	-	-	100,000
Jan 23, 2023	Vincent Mark D.	director	-	A-Award	Buy	100,000	-	-	100,000
Jan 23, 2023	Seizinger Bernd R.	director	-	A-Award	Buy	100,000	-	-	100,000
Jan 23, 2023	Rice William G.	officer	Chair, President & CEO	A-Award	Buy	150,000	-	-	513,252
Jan 23, 2023	Rice William G.	officer	Chair, President & CEO	A-Award	Buy	400,000	-	-	400,000
Jan 23, 2023	PLATZER ERICH	director	-	A-Award	Buy	100,000	-	-	100,000
Jan 23, 2023	Payne Fletcher	officer	SR VP & Chief Fin. Officer	A-Award	Buy	200,000	-	-	200,000
Jan 23, 2023	Payne Fletcher	officer	SR VP & Chief Fin. Officer	A-Award	Buy	100,000	-	-	100,000

The last insider buy of APTO was made by Seizinger Bernd R. on Sep 25 2023, buying 17,000 shares at $3.14 per share (worth $53.38K).

Aptose Biosciences Insider Ownership Trends

All Insider Trades Trend

Date	Buy	Sell	Buy/Sell Ratio
Q2 2027	-	1	-
Q1 2024	10	-	-
Q3 2023	1	-	-
Q1 2023	14	-	-
Q3 2022	4	-	-
Q2 2022	3	1	300.00%
Q1 2022	9	-	-
Q4 2021	14	2	700.00%
Q3 2021	4	1	400.00%
Q2 2021	-	2	-
Q1 2021	10	-	-
Q4 2020	1	3	33.33%
Q3 2020	-	4	-
Q2 2020	12	4	300.00%
Q1 2020	28	-	-
Q4 2019	1	-	-
Q2 2019	4	1	400.00%
Q1 2019	15	-	-
Q4 2018	-	6	-
Q3 2018	-	1	-

0 total buy trades, and 1 total sell trades (buy/sell ratio of 0.00%) were made by Aptose Biosciences's insiders, as of Q2 2027.

Open Market Insider Trades Trend

Date	Buy	Sell	Buy/Sell Ratio
Q2 2027	-	-	-
Q1 2024	-	-	-
Q3 2023	1	-	-
Q1 2023	-	-	-
Q3 2022	1	-	-
Q2 2022	1	-	-
Q1 2022	-	-	-
Q4 2021	12	-	-
Q3 2021	2	1	200.00%
Q2 2021	-	2	-
Q1 2021	-	-	-
Q4 2020	-	2	-
Q3 2020	-	4	-
Q2 2020	-	4	-
Q1 2020	1	-	-
Q4 2019	1	-	-
Q2 2019	2	-	-
Q1 2019	5	2	250.00%
Q4 2018	-	-	-
Q3 2018	-	-	-

As of Q2 2027, Insider owners conducted 0 open market buy trades and 0 open market sell trades of Aptose Biosciences's stocks.

Aptose Biosciences Peer Ownership

Ticker	Company
SPRO	Spero Therapeutics, Inc.
TFFP	TFF Pharmaceuticals, Inc.
TIL	Instil Bio, Inc.
CRVS	Corvus Pharmaceuticals, Inc.
INAB	IN8bio, Inc.
LTRN	Lantern Pharma Inc.
ADAP	Adaptimmune Therapeutics plc
FBIO	Fortress Biotech, Inc.
MBIO	Mustang Bio, Inc.
TCON	TRACON Pharmaceuticals, Inc.
CTMX	CytomX Therapeutics, Inc.
AFMD	Affimed N.V.
ONCT	Oncternal Therapeutics, Inc.
GANX	Gain Therapeutics, Inc.
LBPH	Longboard Pharmaceuticals, Inc.
ACHL	Achilles Therapeutics plc
LPTX	Leap Therapeutics, Inc.
AGLE	Spyre Therapeutics, Inc.
NLTX	Neurogene Inc.
ASMB	Assembly Biosciences, Inc.
LIFE	aTyr Pharma, Inc.

APTO Ownership FAQ

Who Owns Aptose Biosciences?

Aptose Biosciences is owned by institutional shareholders (0.00%), insiders (17.11%), and public (82.89%). The largest institutional shareholder of Aptose Biosciences is ANNANDALE CAPITAL, LLC (0.39% of total shares) and the top mutual fund owner is DRIEHAUS MUTUAL FUNDS (0.02% of total shares).

Who are the major institutional shareholders of Aptose Biosciences?

Aptose Biosciences's major institutional shareholders are ANNANDALE CAPITAL, LLC, and CALDWELL SUTTER CAPITAL, INC.. The top five shareholders own together 0.40% of the company's share outstanding.

How many Aptose Biosciences shareholders are there?

As of Mar 2024, there are 1 institutional shareholders of Aptose Biosciences.

What percentage of Aptose Biosciences is owned by ANNANDALE CAPITAL, LLC?

ANNANDALE CAPITAL, LLC owns 26.67K shares of Aptose Biosciences, representing 0.39% of the company's total shares outstanding, valued at $44K (as of Mar 2024).

What percentage of Aptose Biosciences is owned by CALDWELL SUTTER CAPITAL, INC?

As of Mar 2024, CALDWELL SUTTER CAPITAL, INC holds 92 shares of Aptose Biosciences (APTO), compromising 0.00% of the company, valued at $153.